Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Mismatch Repair01:20

Mismatch Repair

4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Regulation of urea cycle by reversible high-stoichiometry lysine succinylation.

Nature metabolism·2026
Same author

Exercise suppresses breast cancer and reprograms the immune tumor microenvironment, cancer cell intrinsic features, and their interaction.

Journal of sport and health science·2026
Same author

Gut metabolism links precision nutrition, exercise, and healthspan in <i>Drosophila melanogaster</i>.

bioRxiv : the preprint server for biology·2025
Same author

Author Correction: The Asprosin-OLFR734 hormonal signaling axis modulates male fertility.

Cell discovery·2025
Same author

Author Correction: A feeding-induced myokine modulates glucose homeostasis.

Nature metabolism·2025
Same author

Flux measurements of the tricarboxylic acid cycle in the tumors of mice.

Life metabolism·2025

Related Experiment Video

Updated: Jul 20, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.4K

Methionine restriction and antitumor immunity.

Fangchao Wei1, Jason W Locasale1

  • 1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA.

Trends in Cancer
|July 30, 2023
PubMed
Summary
This summary is machine-generated.

Methionine restriction boosts anti-cancer immunity by improving cyclic GMP-AMP synthase (cGAS) function and chromatin release. This suggests targeting methionine metabolism could be a novel cancer therapy strategy.

Keywords:
antitumor immunitycGAS methylationmethionine restriction

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.6K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K

Related Experiment Videos

Last Updated: Jul 20, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.4K
Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.6K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K

Area of Science:

  • Immunology
  • Metabolic pathways
  • Cancer biology

Background:

  • Methionine is an essential amino acid crucial for various cellular processes.
  • Dysregulated methionine metabolism is implicated in cancer development and progression.
  • Cyclic GMP-AMP synthase (cGAS) is a key innate immune sensor involved in DNA detection and immune activation.

Purpose of the Study:

  • To investigate the impact of methionine restriction on antitumor immunity.
  • To elucidate the role of cyclic GMP-AMP synthase (cGAS) in mediating the effects of methionine restriction.
  • To explore the potential of targeting methionine metabolism for cancer therapy.

Main Methods:

  • Utilized a methionine-restricted diet in preclinical cancer models.
  • Assessed immune cell activity and tumor growth.
  • Analyzed cGAS activation, chromatin binding, and demethylation status.

Main Results:

  • Methionine restriction significantly enhanced antitumor immunity.
  • This enhancement was associated with increased cGAS activity.
  • Methionine restriction promoted the dissociation of cGAS from chromatin, potentially via demethylation.

Conclusions:

  • Methionine restriction represents a promising strategy to augment antitumor immunity.
  • Targeting cGAS activity and its chromatin association is a viable therapeutic approach in cancer.
  • Modulating methionine metabolism offers a novel avenue for cancer treatment development.